Fifteen general practitioners conducted a randomized, double-blind comparative trial of two cerumenolytics, namely, Otocerol® and Cerumol®. A total of 106 patients were entered into the study (fifty-three in each group). Otocerol was shown to be marginally better than Cerumol in all parameters evaluated.
Get full access to this article
View all access options for this article.
References
1.
Morbidity Statistics from General Practice, 2nd National Study 1970-71, Studies on Medical and Population Subjects No 26, HMSO.
